• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: agent

  • Front Line Therapy in Non-Small Cell Lung Cancer
    • in Oncology
    • — 17 Mar, 2008

    Front Line Therapy in Non-Small Cell Lung Cancer

    Nick Thatcher
    Nick Thatcher

    NICK THATCHER, Christie Hospital, Manchester
    There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his
    …
    Read more
    Audio Journal of Oncology in Advance – March 15th, 2008
    • in Oncology
    • — 16 Mar, 2008

    Audio Journal of Oncology in Advance – March 15th, 2008

    Volume 16 Number 6 (March 15th, 2008) reporting from:
    4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
    American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
    Chemotherapy Foundation Symposium, November 7-10, 2007, New York

    David Maloney
    David Maloney

    Nonmyeloablative

    …
    Read more
  • Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
    • in News · Oncology
    • — 26 Feb, 2008

    Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

    Martin Dreyling
    Martin Dreyling

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    MARTIN DREYLING, University Hospital Grosshaden, Munich
    Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He
    …
    Read more
    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

    Pierre Fenaux
    Pierre Fenaux

    PIERRE FENAUX, Paris 13 University
    Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
    …
    Read more
  • New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
    Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
    • in Cardiovascular
    • — 6 Nov, 2007

    Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

    Ake Hjalmarson
    Ake Hjalmarson
    Gordon Tomaselli
    Gordon Tomaselli

    REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    N Engl J Med 2007;357

    AKE HJALMARSON, Sahlgrenska University, Göteborg
    COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltimore

    The lipid
    …
    Read more
  • TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
    • in Cardiovascular
    • — 5 Nov, 2007

    TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

    Gordon Tomaselli
    Gordon Tomaselli
    Daniel Jones
    Daniel Jones

    REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
    GORDON TOMASELLI, Johns Hopkins University, Baltimore
    COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson

    A potential new
    …
    Read more
    Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer
    • in Oncology
    • — 2 Nov, 2007

    Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer

    Nicholas James
    Nicholas James
    Gordon McVie
    Gordon McVie

    REFERENCE: Abstract: 3LB (Presidential Session), ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    NICHOLAS JAMES, Birmingham University
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    A new drug has improved overall survival
    …
    Read more
  • DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
    • in General Medicine
    • — 21 Sep, 2007

    DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

    Pedro Cahn
    Pedro Cahn

    REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires
    Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week
    …
    Read more
    Hospital Hand Hygiene Program Successfully Rolled Out
    • in General Medicine
    • — 21 Sep, 2007

    Hospital Hand Hygiene Program Successfully Rolled Out

    Lindsay Grayson
    Lindsay Grayson

    REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    LINDSAY GRAYSON, Austin Hospital, Victoria, Australia
    A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and
    …
    Read more
  • BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns
    • in General Medicine
    • — 21 Sep, 2007

    BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

    Jennifer Lavrrar, Jane Hata, Jeanette Block
    Jennifer Lavrrar, Jane Hata, Jeanette Block

    REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    JANE HATA, bioMéríeux Inc, Durham
    Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter
    …
    Read more
    Vancomycin: New Guidelines May Induce Kidney Damage
    • in Public Health
    • — 19 Sep, 2007

    Vancomycin: New Guidelines May Induce Kidney Damage

    Megan Nguyen
    Megan Nguyen

    REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    MEGAN NGUYEN, Western University in Pomona, California
    New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: agent

© COPYRIGHT 2020 AUDIOMEDICA.COM.